PROCESE Y DESARROLLO
BIC
Harvard Medical School
Boston, Estados UnidosHarvard Medical School-ko ikertzaileekin lankidetzan egindako argitalpenak (7)
2023
-
Characterization of Ly108-H1 Signaling Reveals Ly108-3 Expression and Additional Strain-Specific Differences in Lupus Prone Mice
International Journal of Molecular Sciences, Vol. 24, Núm. 5
-
Multistep IgE Mast Cell Desensitization Is a Dose- and Time-Dependent Process Partially Regulated by SHIP-1
Journal of Immunology, Vol. 210, Núm. 6, pp. 709-720
2022
-
SLAMF8 Downregulates Mouse Macrophage Microbicidal Mechanisms via PI3K Pathways
Frontiers in Immunology, Vol. 13
2012
-
Cutting edge: Slamf8 is a negative regulator of Nox2 activity in macrophages
Journal of Immunology, Vol. 188, Núm. 12, pp. 5829-5832
2006
-
CD48 Controls T-Cell and Antigen-Presenting Cell Functions in Experimental Colitis
Gastroenterology, Vol. 130, Núm. 2, pp. 424-434
2005
-
Defective B cell responses in the absence of SH2D1A
Proceedings of the National Academy of Sciences of the United States of America, Vol. 102, Núm. 13, pp. 4819-4823
2004
-
Cutting Edge: The Natural Ligand for Glucocorticoid-Induced TNF Receptor-Related Protein Abrogates Regulatory T Cell Suppression
Journal of Immunology, Vol. 172, Núm. 10, pp. 5823-5827